Global Capillary Sequencing Market Strategic Research Report

Scope of the Report

The global Capillary Sequencing market size is predicted to grow from US$ 599 million in 2025 to US$ 842 million in 2032; it is expected to grow at a CAGR of 5.0% from 2026 to 2032.

Capillary sequencing is a DNA sequence reading method based on the dideoxy chain termination method as its core chemical principle, and fluorescently labeled terminators and capillary electrophoresis separation and detection as key technical pathways. Capillary sequencing focuses on instrument systems, sequencing reaction reagents, capillary arrays and polymer consumables, base recognition and peak analysis software, and commercial Sanger sequencing service platforms with in-house laboratory capabilities for small-scale, targeted, confirmatory DNA sequence analysis.

From a demand structure perspective, the growth momentum of Sanger sequencing mainly comes from existing essential needs rather than emerging explosive growth. Plasmid validation and PCR product sequencing remain fundamental requirements in academic research. Pharmaceutical and synthetic biology companies continue to rely on Sanger as a low-cost, highly reliable validation tool for plasmid, vector, edited site, construct, and key sequence confirmation. Clinical laboratories retain Sanger workflows for some single-gene testing, validation of known family variants, and confirmation of NGS positive results. Overall, the unit price of routine reads remains under pressure, but high-complexity templates, compliant services, and rapid localized delivery will maintain a certain profit margin.

This report presents a comprehensive overview of the global Capillary Sequencing market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Capillary Gel Electrophoresis (CGE)
• Non-gel Matrix Capillary Electrophoresis

Segment by Array Size

• Single Capillary
• 8 Capillaries
• 96/384 Capillaries

Segment by Effective Sequencing Range

• < 700 bp
• 700–1000 bp
• > 1000 bp

Segment by Application

• Clinical Medicine
• Gene Therapy
• Forensic Identification
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Capillary Sequencing market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Clinical Medicine, Gene Therapy, Forensic Identification evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact